Venn Therapeutics

Mason
Ohio
45040
United States

Show jobs for this employer

About Venn Therapeutics

At Venn Therapeutics, we are focused on developing novel, first-in-class drugs that polarize tumor-resident innate immune cells to an anti-tumor phenotype and reverse the immunosuppressive microenvironment found within tumors. Powering the immune system is our focus and we welcome the opportunity to work with other companies to advance innovative cancer therapies from research labs to patient bedside. Our approach has been to form collaborations with academic researchers in order to fund the development and clinical validation of novel immunotherapies.
YEAR FOUNDED:
2015
LEADERSHIP:
CEO: Sam Shrivastava
PIPELINE:
Please click here for ImmunoMet Therapeutics' pipeline.

2 articles with Venn Therapeutics